Journal of Medicinal Chemistry · 1996 · 189 citations · 14 references
MedicineMedicinal ChemistryPharmacologyNeuropharmacologyPsychopharmacologyStructure-activity RelationshipsAntipsychotic PharmacologyAntipsychotic TherapyDopaminergic PharmacologyLead Compound DesignSerotonergic PharmacologyStructure-activity Relationship Analysis5-Hydroxytryptamine Receptor PharmacologyAntipsychotic ActionBiological Activity FeaturesD2-like Dopamine ReceptorsDopamine D2-like ReceptorsSerotonergic Drug DiscoverySpacer DesignSubstituent Effects On Biological Activity
A series of phthalimide and isoindolinone derivatives bridged to 4-(1,2-benzisothiazol-3-yl)-1-piperazinyl was prepared. The compounds were evaluated in vitro at dopamine D2 and serotonin 5-HT1a and 5-HT2 receptors and in vivo for their ability to antagonize the apomorphine-induced climbing response in mice. The effects of bridge length and conformation on the biological activity of these potential antipsychotic agents are discussed. A four-carbon spacer provided optimal activity within the two homologous series. Conformational investigations of the lead compound, isoindolinone 2, were conducted in an attempt to account for the superior activity observed for the butyl derivatives. On the basis of NMR and molecular modeling studies, two types of folded structures were proposed and several conformationally restrained analogues were synthesized. In general, restrictions incorporated within the linking bridge were detrimental to activity.
14
Clozapine for the Treatment-Resistant Schizophrenic
John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations
Medicine, Pharmacology, Psychiatry +16
Joseph P. Yevich, James S. New, David W. Smith et al. · Journal of Medicinal Chemistry · 1986 · 114 citations · Full text
Annual Reports in Medicinal Chemistry, 1965.
Annals of Internal Medicine · 1967 · 107 citations